Harrow, Inc. Proceeds from Issuance of Warrants
Harrow, Inc. (HROW) reported Proceeds from Issuance of Warrants of $37.49 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2014-08-13
- Harrow, Inc. proceeds from issuance of warrants for the quarter ending 2014-06-30 was $18.75K.
- Harrow, Inc. proceeds from issuance of warrants for the quarter ending 2014-03-31 was $18.75K.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month |
|---|---|---|
| 2014-06-30 | $18.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $37.49K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $18.75K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |